Clinical Trials Logo

Clinical Trial Summary

This work seeks to develop, evaluate and use new MRI methods for non-invasive quantitative assessment of myocardial perfusion and perfusion reserve (MPR), and to compare with quantitative PET imaging.


Clinical Trial Description

This project aims to determine the validity of quantitative MRI perfusion methods by comparison with quantitative PET imaging. First pass dynamic contrast enhanced MRI scans will be performed at rest and during hyperemia caused by either adenosine infusion or regadenoson. After custom reconstruction and post-processing the data will be fit to a compartment model and quantitative perfusion and MPR values obtained.

On another day, the subjects will have quantitative PET imaging with O-15 labeled radioactive water. This will be done at rest and hyperemia caused by either adenosine or regadenoson. A low dose CT scan will be acquired to perform attenuation correction of the PET images. The images will be reconstructed and processed as reported in the literature to provide reference standard perfusion and MPR values. These values will be compared with those obtained by MRI. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02608944
Study type Interventional
Source University of Utah
Contact
Status Withdrawn
Phase N/A
Start date September 30, 2012
Completion date June 12, 2019

See also
  Status Clinical Trial Phase
Completed NCT04448600 - Bone Conduction Implant and MRI
Recruiting NCT04600115 - New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF) Early Phase 1
Recruiting NCT03891511 - TMJ Fibrocartilage Detection Using MRI
Not yet recruiting NCT04871555 - Structural Cartography of the Insula in Temporal Epilepsy Patients
Completed NCT02318550 - Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD
Recruiting NCT04171635 - Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy